Cancer care does not end when treatment targets the tumour. Comprehensive cancer care considers the patient's entire journey, from diagnosis through treatment and long-term follow-up. Each stage can bring different physical, emotional, and psychological challenges. Anxiety may emerge before treatment, during procedures, after treatment completion, or around surveillance. These concerns can influence symptoms, sleep, treatment adherence, and healthcare engagement.

A longitudinal approach helps clinicians identify these changes at clinically relevant points. This article follows the sequence of diagnosis, treatment, emotional well-being, anxiety, treatment completion, surveillance, and survivorship. It also examines the role of anxiety-focused oncology care proposed by Dr. Chirag Jain.

Key Takeaways

● Comprehensive cancer care extends clinical attention beyond tumour-directed therapy.

● Anxiety can change across different stages of the cancer trajectory.

● Treatment completion can create a new period of psychological vulnerability.

● Surveillance may trigger fear of recurrence and anticipatory anxiety.

● Survivorship includes physical, psychological, and long-term healthcare needs.

● Dr. Chirag Jain has proposed onco-anxiology as a longitudinal anxiety-focused framework within psycho-oncology.

1. Diagnosis: The First Point of Psychological Risk

Diagnosis creates uncertainty about prognosis, treatment, and future health. Anxiety can begin even before a confirmed diagnosis. It may increase while patients await investigations, pathology results, or staging.

The clinical task is not limited to delivering the diagnosis. It also involves identifying distress that may affect decision-making and engagement with care.

Attention to psychosocial needs therefore begins with recognising psychological needs alongside diagnostic planning.

Important clinical considerations include:

● Anxiety severity and functional impact

● Sleep disturbance

● Previous psychiatric history

● Understanding of the diagnosis

● Social and family support

● Ability to participate in treatment decisions

2. Treatment: Anxiety Can Interact With Physical Symptoms

Cancer treatment can involve surgery, chemotherapy, radiotherapy, immunotherapy, or combinations of these approaches. Treatment-related symptoms may overlap with anxiety symptoms.

For example, nausea, pain, fatigue, palpitations, and sleep problems can increase distress. Anxiety can also intensify the perception of physical symptoms.

Dr. Chirag Jain's research focuses on this interaction between cancer treatment and the nervous system. A published protocol outlines a planned randomised trial involving 70 patients with head and neck cancer receiving radiotherapy and/or chemotherapy, to compare heart-rate-variability-guided adaptive music with static music. Clinical effectiveness remains under investigation.

3. Emotional Well-Being Is Part of Clinical Care

Emotional well-being should not be treated as an optional addition to cancer treatment. Psychological symptoms can affect quality of life and engagement with healthcare.

The distinction between cancer anxiety and depression is clinically relevant. Anxiety often involves hypervigilance, anticipatory fear, and autonomic arousal. Depression more commonly involves low mood, anhedonia, and withdrawal.

The proposed onco-anxiology framework focuses specifically on anxiety within psycho-oncology. It uses a longitudinal approach rather than treating anxiety as an isolated event.

4. Anxiety: A Longitudinal Clinical Concern

Comprehensive cancer care calls for anxiety assessment across multiple clinical time points. Anxiety is not necessarily constant throughout the cancer journey.

Dr. Jain's 2026 peer-reviewed Perspective discusses population-level periods of increased vulnerability (Jain, Frontiers in Psychology, 2026; doi:10.3389/fpsyg.2026.1939608):

● Diagnosis and uncertainty

● Active treatment and anticipatory symptoms

● Treatment completion

● Surveillance imaging

● Fear of recurrence

● Recurrence or disease progression

Fear of cancer recurrence is particularly relevant during survivorship. Research indicates that fear of recurrence affects many survivors, with higher questionnaire scores reported in a substantial subgroup. Estimates depend on the population and cut-off applied.

This supports a shift from reactive psychological referral toward planned anxiety assessment.

5. Treatment Completion: The End of Therapy Is Not the End of Care

Treatment completion can bring relief, but it can also remove the structure of frequent clinical contact. Some patients may feel uncertain about what happens next.

A survivorship plan should address:

● Expected follow-up

● Potential late effects

● Symptoms requiring medical review

● Emotional concerns

● Lifestyle and health promotion

● Communication between healthcare providers

Follow-up care is recommended after cancer treatment, including assessment of physical and emotional problems that may develop months or years later.

6. Surveillance: Monitoring Disease and Managing Fear

Surveillance aims to identify recurrence, treatment-related complications, and other health problems. Its schedule depends on the cancer type, treatment received, and individual clinical factors. However, surveillance can also become an anxiety trigger. Waiting for imaging or laboratory results may produce anticipatory fear.

Follow-up care should therefore include both medical surveillance and attention to psychological responses around surveillance.

Surveillance for recurrence and the management of psychological effects are recognised as important components of survivorship care.

7. Survivorship: Continuing Care After Active Treatment

Survivorship is broader than being declared free of active disease. It refers to the period of care that begins at cancer diagnosis and continues throughout the person's life. It focuses on maintaining physical and emotional health, managing long-term treatment effects, monitoring for recurrence, and supporting overall quality of life.

It includes:

● Physical health

● Emotional and psychological health

● Late treatment effects

● Recurrence monitoring

● Second cancer prevention

● Quality of life

● Long-term health promotion

Comprehensive cancer care therefore represents a continuum rather than a single post-treatment phase.

8. Why a Longitudinal Anxiety Framework Matters

Dr. Chirag Jain has proposed onco-anxiology as an anxiety-focused framework within psycho-oncology. The proposal has three central commitments:

● Anxiety-specific clinical targeting

● Longitudinal assessment across the cancer timeline

● Attention to cancer-specific mechanisms

The framework does not replace psycho-oncology. Instead, it proposes a more focused way to identify and manage anxiety across clinically important stages.

For researchers and oncology professionals, this approach raises important questions about screening, treatment adherence, fear of recurrence, physiological measurement, and long-term outcomes.

Conclusion

Comprehensive cancer care requires clinicians to follow the patient's experience across the entire cancer trajectory. Diagnosis, treatment, emotional well-being, anxiety, treatment completion, surveillance, and survivorship are connected clinical stages.

A longitudinal approach can help identify anxiety before it becomes a major barrier to care. It can also support more structured survivorship planning. Dr. Chirag Jain's work contributes to this discussion by proposing anxiety-specific, trajectory-based care within psycho-oncology.

The future of cancer care may depend not only on controlling disease, but also on understanding what patients experience throughout the process.